Ramesh Thakur
Brownstone Institute
September 23, 2022
(AP Photo/Angie Wang, file)
Let’s start with two simple questions. If regulators had the information available to them of the leakage between Covid-19 vaccine efficacy rates in controlled trials and their effectiveness in the real world, would they still grant emergency use authorization? Would their legal framework permit them to do so?